1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow CuraVac: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis CV-MG01, Placebo - Myasthenia Gravis, Generalized | Phase 2 / Phase 3 | Withdrawn | CuraVac | 2018-07-01 | 2018-05-30 | |
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis CV-MG01, Placebo - Myasthenia Gravis | Phase 1 / Phase 2 | Completed | CuraVac | 24 | 2016-03-01 | 2019-01-28 |
Belgium (2)
2015 (1), 2017 (1)